Dong-A Pharm nine-month sales rises 13%

Published: 2004-11-16 06:56:00

Updated: 2004-11-16 06:56:00

Dong-A Pharm, Korea's leading drug maker, said it posted sales of 412.3 billion won for the nine months of this year, up 13.19 percent compared with 364.2 billion won a year ago, due to continued robust sales of prescription drugs such as Stilene, Gaster and Epocerin, albeit sluggish sales in OTC...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK